100 related articles for article (PubMed ID: 17665570)
21. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
22. [The role of D2 lymphadenectomy in the surgical treatment of gastric carcinoma].
Buris L; Halász L; Sasi SL; Czakó D
Magy Seb; 2002 Aug; 55(4):257-60. PubMed ID: 12236082
[TBL] [Abstract][Full Text] [Related]
23. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
24. [Rational evaluation of different lymph node dissection].
Chen JQ; Wang SB; Qi CL
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
[TBL] [Abstract][Full Text] [Related]
25. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
26. Robotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization.
Kim YM; Son T; Kim HI; Noh SH; Hyung WJ
Ann Surg Oncol; 2016 Aug; 23(8):2409-10. PubMed ID: 26957501
[TBL] [Abstract][Full Text] [Related]
27. [Pre- and intraoperative radiotherapy for locally advanced gastric cancer in conjunction with extended lymph node dissection: results of phase II clinical study].
Skoronad VIu; Berdov BA; Mardynskiĭ IuS; Titova LN; Pakhomenko KV
Vopr Onkol; 2004; 50(5):585-9. PubMed ID: 15715102
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect of laparoscopy-assisted D2 radical gastrectomy in 106 patients with advanced gastric cancer.
Li ZX; Xu YC; Lin WL; Chen J; Wu HY
J BUON; 2013; 18(3):689-94. PubMed ID: 24065484
[TBL] [Abstract][Full Text] [Related]
29. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
31. Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation.
Yoon HI; Chang JS; Lim JS; Noh SH; Hyung WJ; An JY; Lee YC; Rha SY; Kim KH; Koom WS
Radiother Oncol; 2013 Jul; 108(1):72-7. PubMed ID: 23777669
[TBL] [Abstract][Full Text] [Related]
32. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
33. [Lymphodissection in the treatment of early stomach cancer: D1 or D2?].
Davydov MI; Turkin IN
Vestn Ross Akad Med Nauk; 2011; (12):9-13. PubMed ID: 22379883
[TBL] [Abstract][Full Text] [Related]
34. A 10-year experience of intraoperative radiotherapy for gastric carcinoma and a new surgical method of creating a wider irradiation field for cases of total gastrectomy patients.
Ogata T; Araki K; Matsuura K; Kobayashi M; Inomata T; Yasuhiro O; Yoshida S
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):341-7. PubMed ID: 7751175
[TBL] [Abstract][Full Text] [Related]
35. Severity of complications and long-term survival after laparoscopic total gastrectomy with D2 lymph node dissection for advanced gastric cancer: A propensity score-matched, case-control study.
Li Z; Bai B; Zhao Y; Yu D; Lian B; Liu Y; Zhao Q
Int J Surg; 2018 Jun; 54(Pt A):62-69. PubMed ID: 29698790
[TBL] [Abstract][Full Text] [Related]
36. Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma: prospective cohort study.
Jeong O; Park YK; Ryu SY; Kim YJ
Ann Surg Oncol; 2010 Jun; 17(6):1589-96. PubMed ID: 20099039
[TBL] [Abstract][Full Text] [Related]
37. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
[TBL] [Abstract][Full Text] [Related]
38. Nasogastric decompression is not necessary in operations for gastric cancer: prospective randomised trial.
Yoo CH; Son BH; Han WK; Pae WK
Eur J Surg; 2002; 168(7):379-83. PubMed ID: 12463426
[TBL] [Abstract][Full Text] [Related]
39. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
